Author: Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine
### he/him/his @@@ Berkley E. Gryder, PhD – Case Western Reserve University ### 2102119###Co-Author######Case Western Reserve University###Co-Author: Berkley E. Gryder, PhD – Case Western Reserve University
### @@@ Jonathan Nakashima, PhD – Certis Oncology ### 2102120###Co-Author######Certis Oncology###Co-Author: Jonathan Nakashima, PhD – Certis Oncology
### @@@ Monica M. Mita, MD – Cedars-Sinai, Samuel Oschin Cancer Center ### 2102121###Co-Author######Cedars-Sinai, Samuel Oschin Cancer Center###Co-Author: Monica M. Mita, MD – Cedars-Sinai, Samuel Oschin Cancer Center
### @@@ Alain C. Mita, MD – Cedars-Sinai, Samuel Oschin Cancer Center ### 2102122###Co-Author######Cedars-Sinai, Samuel Oschin Cancer Center###Co-Author: Alain C. Mita, MD – Cedars-Sinai, Samuel Oschin Cancer Center
### @@@ Noah Federman, MD – David Geffen School of Medicine, University of California, Los Angeles ### 2102123###Co-Author###Professor###David Geffen School of Medicine, University of California, Los Angeles###Co-Author: Noah Federman, MD – David Geffen School of Medicine, University of California, Los Angeles
### @@@ Drew W. Rasco, MD – START Center for Cancer Care ### 2102124###Co-Author######START Center for Cancer Care###Co-Author: Drew W. Rasco, MD – START Center for Cancer Care
### @@@ David Spigel, MD – Sarah Cannon Research Institute at Tennessee Oncology ### 2102125###Co-Author######Sarah Cannon Research Institute at Tennessee Oncology###Co-Author: David Spigel, MD – Sarah Cannon Research Institute at Tennessee Oncology
### @@@ Jia Luo, MD – Dana-Farber Cancer Institute ### 2102126###Co-Author###Instructor###Dana-Farber Cancer Institute###Co-Author: Jia Luo, MD – Dana-Farber Cancer Institute
### @@@ Diana H. Chin, BS – Case Western Reserve University ### 2102127###Co-Author######Case Western Reserve University###Co-Author: Diana H. Chin, BS – Case Western Reserve University
### @@@ Gregory M. Cote, MD, PhD (he/him/his) – Mass General Cancer Center ### 2102128###Co-Author###Assistant Professor###Mass General Cancer Center###Co-Author: Gregory M. Cote, MD, PhD (he/him/his) – Mass General Cancer Center
### he/him/his @@@ Richard E. Cutler, Jr., PhD (he/him/his) – Kronos Bio ### 2102129###Co-Author###Vice President###Kronos Bio###Co-Author: Richard E. Cutler, Jr., PhD (he/him/his) – Kronos Bio
### he/him/his @@@ Pavan Kumar, PhD – Kronos Bio ### 2102130###Co-Author######Kronos Bio###Co-Author: Pavan Kumar, PhD – Kronos Bio
### @@@ Tressa R. Hood, MS (she/her/hers) – Kronos Bio ### 2102131###Co-Author###Associate Director Translation Data###Kronos Bio###Co-Author: Tressa R. Hood, MS (she/her/hers) – Kronos Bio
### she/her/hers @@@ Luis A. Carvajal, PhD – Kronos Bio ### 2102132###Co-Author######Kronos Bio###Co-Author: Luis A. Carvajal, PhD – Kronos Bio
### @@@ Crystal J. MacKenzie, BS – Kronos Bio ### 2102133###Co-Author######Kronos Bio###Co-Author: Crystal J. MacKenzie, BS – Kronos Bio
### @@@ Charles Y. Lin, PhD – Kronos Bio ### 2102134###Co-Author######Kronos Bio###Co-Author: Charles Y. Lin, PhD – Kronos Bio
### @@@ Jorge F. DiMartino, MD, PhD (he/him/his) – Kronos Bio ### 2102135###Co-Author###Chief Medical Officer, Executive VP Clinical Development###Kronos Bio###Co-Author: Jorge F. DiMartino, MD, PhD (he/him/his) – Kronos Bio
### he/him/his @@@ Elizabeth A. Olek, DO, MPH – Kronos Bio ### 2102136###Co-Author###Clinical Development ###Kronos Bio###Co-Author: Elizabeth A. Olek, DO, MPH – Kronos Bio
### @@@ Miguel A. Villalona-Calero, MD (he/him/his) – City of Hope National Medical Center ### 2102138###Co-Author###Director Early Therapeutics###City of Hope National Medical Center###Co-Author: Miguel A. Villalona-Calero, MD (he/him/his) – City of Hope National Medical Center
### he/him/his Paper 26Author: Michael J. Wagner, MD (he/him/his) – Dana Farber Cancer Institute
### he/him/his @@@ Edward L. Briercheck, MD/PhD (he/him/his) – Dana Farber Cancer Institute ### 2101919###Co-Author###Physician###Dana Farber Cancer Institute###Co-Author: Edward L. Briercheck, MD/PhD (he/him/his) – Dana Farber Cancer Institute
### he/him/his @@@ J. Michael Wrigglesworth, B.A. – The Max Foundation ### 2101920###Co-Author######The Max Foundation###Co-Author: J. Michael Wrigglesworth, B.A. – The Max Foundation
### @@@ Philip Stevenson, M.S. – Fred Hutch Cancer Center ### 2101921###Co-Author######Fred Hutch Cancer Center###Co-Author: Philip Stevenson, M.S. – Fred Hutch Cancer Center
### @@@ Alicia A. Annamalay, PhD – The Max Foundation ### 2101922###Co-Author######The Max Foundation###Co-Author: Alicia A. Annamalay, PhD – The Max Foundation
### @@@ David G. Coffey, M.D. – University of Miami ### 2101923###Co-Author######University of Miami###Co-Author: David G. Coffey, M.D. – University of Miami
### @@@ Aparna Anderson, PhD – The Max Foundation ### 2101924###Co-Author######The Max Foundation###Co-Author: Aparna Anderson, PhD – The Max Foundation
### @@@ Pat Garcia- Gonzalez, M.S. – The Max Foundation ### 2101925###Co-Author###CEO###The Max Foundation###Co-Author: Pat Garcia- Gonzalez, M.S. – The Max Foundation
### Paper 01Author: Mark Fairweather, MD – Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston
### @@@ Jolissaint S. Joshua, MD, MSc – Department of Surgery, Memorial Sloan Kettering, Cancer Center ### 2102419###Co-Author###Fellow###Department of Surgery, Memorial Sloan Kettering, Cancer Center###Co-Author: Jolissaint S. Joshua, MD, MSc – Department of Surgery, Memorial Sloan Kettering, Cancer Center
### @@@ Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102380###Co-Author###Attending Surgical Oncologist###Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Dirk Strauss, MD – Royal Marsden NHS Foundation Trust ### 2101967###Co-Author###Surgical Oncologist###Royal Marsden NHS Foundation Trust###Co-Author: Dirk Strauss, MD – Royal Marsden NHS Foundation Trust
### @@@ Sylvie Bonvalot, MD, PhD – Institut Curie ### 2101969###Co-Author###Head, Sarcoma surgery###Institut Curie###Co-Author: Sylvie Bonvalot, MD, PhD – Institut Curie
### @@@ Samuel Ford, MD, PhD – Department of Surgery, University Hospitals Birmingham ### 2102420###Co-Author######Department of Surgery, University Hospitals Birmingham###Co-Author: Samuel Ford, MD, PhD – Department of Surgery, University Hospitals Birmingham
### @@@ Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2101972###Co-Author###Surgical Oncology###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###Co-Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada ### 2101979###Co-Author######Mount Sinai Hospital, Toronto, ON, Canada###Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada
### @@@ Piotr Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma ### 2101886###Co-Author###Head of Department of Soft Tissue/Bone Sarcoma and Melanoma###Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma###Co-Author: Piotr Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma
### @@@ David E Gyorki, MD (he/him/his) – Peter MacCallum Cancer Centre ### 2102421###Co-Author###Surgical Oncologist###Peter MacCallum Cancer Centre###Co-Author: David E Gyorki, MD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/his @@@ Migalie Fau, MD – Department of Surgery, Institut Bergonie ### 2102423###Co-Author######Department of Surgery, Institut Bergonie###Co-Author: Migalie Fau, MD – Department of Surgery, Institut Bergonie
### @@@ John Mullinax, MD – Moffitt Cancer Center ### 2102165###Co-Author###Associate Member###Moffitt Cancer Center###Co-Author: John Mullinax, MD – Moffitt Cancer Center
### @@@ Markus Albertsmeier, MD – Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany ### 2102424###Co-Author###Consultant###Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany###Co-Author: Markus Albertsmeier, MD – Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany
### @@@ Carolyn Nessim, MD (she/her/hers) – Department of Surgery, University of Ottawa ### 2102425###Co-Author###Surgical Oncologist, Associate Professor, Clinician Investigator###Department of Surgery, University of Ottawa###Co-Author: Carolyn Nessim, MD (she/her/hers) – Department of Surgery, University of Ottawa
### she/her/hers @@@ Vittorio Lorenzo Quagliuolo, MD – IRCCS Humanitas Research Hospital ### 2102426###Co-Author###Senior Consultant Sarcoma and Melanoma Unit###IRCCS Humanitas Research Hospital###Co-Author: Vittorio Lorenzo Quagliuolo, MD – IRCCS Humanitas Research Hospital
### @@@ Valerie P. Grignol, MD – The James Cancer Hospital / The Ohio State University ### 2102427###Co-Author###Associate Professor of Surgery###The James Cancer Hospital / The Ohio State University###Co-Author: Valerie P. Grignol, MD – The James Cancer Hospital / The Ohio State University
### @@@ Kenneth Cardona, MD – Department of Surgery, Winship Cancer Institute, Emory University ### 2102428###Co-Author###Associate Chief Medical Officer, Winship Cancer Institute of Emory###Department of Surgery, Winship Cancer Institute, Emory University###Co-Author: Kenneth Cardona, MD – Department of Surgery, Winship Cancer Institute, Emory University
### @@@ José Antonio Gonzalez, MD, PhD – Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain ### 2102429###Co-Author######Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain###Co-Author: José Antonio Gonzalez, MD, PhD – Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
### @@@ Elisabetta Pennacchioli, MD – Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology ### 2102430###Co-Author###Director###Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology###Co-Author: Elisabetta Pennacchioli, MD – Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology
### @@@ Marko Novak, MD – Department of Surgery, Institute of Oncology Ljubljana ### 2102431###Co-Author###Surgical Oncologist###Department of Surgery, Institute of Oncology Ljubljana###Co-Author: Marko Novak, MD – Department of Surgery, Institute of Oncology Ljubljana
### @@@ Marco Rastrelli, MD – Department of Surgery, Veneto Institute of Oncology IOV-IRCCS ### 2102432###Co-Author######Department of Surgery, Veneto Institute of Oncology IOV-IRCCS###Co-Author: Marco Rastrelli, MD – Department of Surgery, Veneto Institute of Oncology IOV-IRCCS
### @@@ Sergio Valeri, MD – Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico ### 2102433###Co-Author###Surgical Oncologist Chair Surgical Sarcoma Service – Department of Surgery ###Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico###Co-Author: Sergio Valeri, MD – Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico
### @@@ Michelle Wilkinson, MD PhD – Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust ### 2102434###Co-Author######Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust###Co-Author: Michelle Wilkinson, MD PhD – Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust
### @@@ Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie ### 2101975###Co-Author###Consultant Surgical Oncologist###Institut Curie###Co-Author: Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie
### he/him/his @@@ Yvonne Schrage, MD, PhD – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2102435###Co-Author###Surgical Oncologist###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###Co-Author: Yvonne Schrage, MD, PhD – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON ### 2101973###Co-Author###Surgical Oncologist Clinician-Scientist Associate Professor of Surgery###Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON###Co-Author: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
### she/her/hers @@@ Jacek Skoczylas, MD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology ### 2102436###Co-Author######Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology###Co-Author: Jacek Skoczylas, MD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his @@@ Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School ### 1137185###Co-Author###Surgical Oncologist###Brigham and Women’s Hospital/Harvard Medical School###Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
### he/him/his Paper 78Author: Filemon S. Dela Cruz, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Prabhjot S. Mundi, M.D. – Department of Medicine, Columbia University ### 2102254###Co-Author###Assistant Professor###Department of Medicine, Columbia University###Co-Author: Prabhjot S. Mundi, M.D. – Department of Medicine, Columbia University
### @@@ Glorymar Ibanez Sanchez, BS – Memorial Sloan Kettering Cancer Center ### 2102281###Co-Author###Research Lab Manager###Memorial Sloan Kettering Cancer Center###Co-Author: Glorymar Ibanez Sanchez, BS – Memorial Sloan Kettering Cancer Center
### @@@ Kristina Guillan, BS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2102282###Co-Author###Research Assistant###Memorial Sloan Kettering Cancer Center###Co-Author: Kristina Guillan, BS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Armaan Siddiquee, MS – Memorial Sloan Kettering Cancer Center ### 2102283###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Armaan Siddiquee, MS – Memorial Sloan Kettering Cancer Center
### @@@ Andrea Califano, PhD – Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University ### 2102258###Co-Author###Professor###Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University###Co-Author: Andrea Califano, PhD – Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University
### @@@ Andrew L. Kung, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2102284###Co-Author###Chair of Pediatrics###Memorial Sloan Kettering Cancer Center###Co-Author: Andrew L. Kung, MD, PhD – Memorial Sloan Kettering Cancer Center
### Paper 74Author: Priscilla Merriam, MD – Dana-Farber Cancer Institute
### @@@ Emanuele Mazzola, PhD – Dana-Farber Cancer Institute ### 2102362###Co-Author######Dana-Farber Cancer Institute###Co-Author: Emanuele Mazzola, PhD – Dana-Farber Cancer Institute
### @@@ Ping Chi, MD, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2101910###Co-Author###Member/Professor and Attending Physician###Memorial Sloan Kettering Cancer Center###Co-Author: Ping Chi, MD, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Alice Chen, MD – Division of Cancer Treatment and Diagnosis, National Cancer Institute ### 2102342###Co-Author###Head, Developmental Therapeutics Clinic###Division of Cancer Treatment and Diagnosis, National Cancer Institute###Co-Author: Alice Chen, MD – Division of Cancer Treatment and Diagnosis, National Cancer Institute
### @@@ Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research ### 2101931###Co-Author###Sarcoma Section Chief###City of Hope, Department of Medical Oncology & Therapeutics Research###Co-Author: Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research
### he/him/his @@@ Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center ### 2101928###Co-Author###-###University of Pittsburgh Medical Center Hillman Cancer Center###Co-Author: Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center
### she/her/hers @@@ Scott M. Schuetze, MD, PhD – University of Michigan ### 2101848###Co-Author###Clinical Professor of Internal Medicine###University of Michigan###Co-Author: Scott M. Schuetze, MD, PhD – University of Michigan
### @@@ Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2101912###Co-Author###Associate Professor and Deputy Chair###The University of Texas MD Anderson Cancer Center###Co-Author: Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine ### 2102118###Co-Author###Professor of Medicine###Washington University School of Medicine###Co-Author: Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine
### he/him/his @@@ Seth Pollack, MD – Robert H. Lurie Comprehensive Cancer Center of Northwestern University ### 2101861###Co-Author###Sarcoma Program Director###Robert H. Lurie Comprehensive Cancer Center of Northwestern University###Co-Author: Seth Pollack, MD – Robert H. Lurie Comprehensive Cancer Center of Northwestern University
### @@@ Gabriel Tinoco, MD – The Ohio State University Comprehensive Cancer Center ### 2102363###Co-Author######The Ohio State University Comprehensive Cancer Center###Co-Author: Gabriel Tinoco, MD – The Ohio State University Comprehensive Cancer Center
### @@@ Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 2101926###Co-Author###Professor of Medicine###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Breelyn A. Wilky, MD (she/her/hers) – University of Colorado Cancer Center ### 2101927###Co-Author###Associate Professor###University of Colorado Cancer Center###Co-Author: Breelyn A. Wilky, MD (she/her/hers) – University of Colorado Cancer Center
### she/her/hers @@@ Nicola Bothwick, BA – Dana-Farber Cancer Institute ### 2102364###Co-Author######Dana-Farber Cancer Institute###Co-Author: Nicola Bothwick, BA – Dana-Farber Cancer Institute
### @@@ Richard Piekarz, MD, PhD – Division of Cancer Treatment and Diagnosis, National Cancer Institute ### 2102365###Co-Author######Division of Cancer Treatment and Diagnosis, National Cancer Institute###Co-Author: Richard Piekarz, MD, PhD – Division of Cancer Treatment and Diagnosis, National Cancer Institute
### @@@ Matthew L. Hemming, MD, PhD – UMass Chan Medical School ### 2102366###Co-Author######UMass Chan Medical School###Co-Author: Matthew L. Hemming, MD, PhD – UMass Chan Medical School
### @@@ Bradley Bernstein, MD, PhD – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School ### 2102367###Co-Author######Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School###Co-Author: Bradley Bernstein, MD, PhD – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
### @@@ Geoffrey I. Shapiro, MD, PhD – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School ### 2102368###Co-Author######Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School###Co-Author: Geoffrey I. Shapiro, MD, PhD – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
### @@@ George Demetri, MD (he/him/his) – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School ### 2102369###Co-Author###Professor and Senior Vice President of Experimental Therapeutics###Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School###Co-Author: George Demetri, MD (he/him/his) – Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
### he/him/his @@@ Suzanne George, MD – Dana-Farber Cancer Institute ### 2101917###Co-Author######Dana-Farber Cancer Institute###Co-Author: Suzanne George, MD – Dana-Farber Cancer Institute
### Paper 84Co-Author: Jayesh Desai, MBBS FRACP – Peter MacCallum Cancer Centre
### @@@ Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute ### 2101852###Co-Author###Associate Professor of Medicine###Dana-Farber Cancer Institute###Co-Author: Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute
### @@@ Irene Carrasco Garcia, MD – Virgen del Rocio University Hospital ### 2102229###Co-Author###Medical Oncologist###Virgen del Rocio University Hospital###Co-Author: Irene Carrasco Garcia, MD – Virgen del Rocio University Hospital
### @@@ Marilena Cesari, MD – Rizzoli Orthopedic Institute ### 2102230###Co-Author######Rizzoli Orthopedic Institute###Co-Author: Marilena Cesari, MD – Rizzoli Orthopedic Institute
### @@@ Michael Gordon, MD – HonorHealth Research Institute ### 2102231###Co-Author######HonorHealth Research Institute###Co-Author: Michael Gordon, MD – HonorHealth Research Institute
### @@@ Chia-Chi Lin, MD, PhD – National Taiwan University Hospital ### 2102232###Co-Author###Professor###National Taiwan University Hospital###Co-Author: Chia-Chi Lin, MD, PhD – National Taiwan University Hospital
### @@@ Zsuzsanna Papai, MD – Semmelweis University ### 2102233###Co-Author######Semmelweis University###Co-Author: Zsuzsanna Papai, MD – Semmelweis University
### @@@ Christopher W. Ryan, MD – OHSU Knight Cancer Institute, South Waterfront ### 2102234###Co-Author######OHSU Knight Cancer Institute, South Waterfront###Co-Author: Christopher W. Ryan, MD – OHSU Knight Cancer Institute, South Waterfront
### @@@ William D. Tap, MD – Memorial Sloan Kettering Cancer Center ### 2101892###Co-Author###Chief, Sarcoma Medical Oncology###Memorial Sloan Kettering Cancer Center###Co-Author: William D. Tap, MD – Memorial Sloan Kettering Cancer Center
### @@@ Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 2101926###Co-Author###Professor of Medicine###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center ### 2101884###Co-Author###Medical Oncologist###Leiden University Medical Center###Co-Author: Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center
### he/him/his @@@ Peter Grimison, MD, PhD – Chris O'Brien Lifehouse ### 2102235###Co-Author###Senior Staff Specialist in Medical Oncology ###Chris O'Brien Lifehouse###Co-Author: Peter Grimison, MD, PhD – Chris O'Brien Lifehouse
### @@@ Antonio López Pousa, MD – Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. ### 2102236###Co-Author######Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.###Co-Author: Antonio López Pousa, MD – Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
### @@@ Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine ### 2102118###Co-Author###Professor of Medicine###Washington University School of Medicine###Co-Author: Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine
### he/him/his @@@ Maria Rubinacci, MS, MBE (she/her/hers) – Daiichi Sankyo, Inc. ### 2102237###Co-Author###Director, Clinical Operations GOMA###Daiichi Sankyo, Inc.###Co-Author: Maria Rubinacci, MS, MBE (she/her/hers) – Daiichi Sankyo, Inc.
### she/her/hers @@@ Kristen Tecson, PhD – Daiichi Sankyo, Inc. ### 2102238###Co-Author###Manager, Biostatistics###Daiichi Sankyo, Inc.###Co-Author: Kristen Tecson, PhD – Daiichi Sankyo, Inc.
### @@@ Margaret Wooddell, PhD, MBA – Daiichi Sankyo, Inc. ### 2102239###Co-Author######Daiichi Sankyo, Inc.###Co-Author: Margaret Wooddell, PhD, MBA – Daiichi Sankyo, Inc.
### @@@ Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102240###Author###Consultant###Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Author: Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers Paper 28Author: John Mullinax, MD – Moffitt Cancer Center
### @@@ Jonathan Hensel, PhD – Quorum Innovations ### 2102166###Co-Author######Quorum Innovations###Co-Author: Jonathan Hensel, PhD – Quorum Innovations
### @@@ Madeline Rodriguez-Valentin, PhD – Moffitt Cancer Center ### 2102167###Co-Author###Research Scientist###Moffitt Cancer Center###Co-Author: Madeline Rodriguez-Valentin, PhD – Moffitt Cancer Center
### @@@ Alejandro Alfaro, BS – Moffitt Cancer Center ### 2102168###Co-Author###Cell Therapy Technologist###Moffitt Cancer Center###Co-Author: Alejandro Alfaro, BS – Moffitt Cancer Center
### @@@ Elizabeth Rau, BS – Moffitt Cancer Center ### 2102169###Co-Author###Research Associate###Moffitt Cancer Center###Co-Author: Elizabeth Rau, BS – Moffitt Cancer Center
### @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Co-Author######Moffitt Cancer Center###Co-Author: Damon Reed, MD – Moffitt Cancer Center
### @@@ Andrew Brohl, MD (he/him/his) – Moffitt Cancer Center ### 2102170###Co-Author###Associate Member###Moffitt Cancer Center###Co-Author: Andrew Brohl, MD (he/him/his) – Moffitt Cancer Center
### he/him/his @@@ Mihaela Druta, MD – H. Lee Moffitt Cancer Center and Research Institute ### 2102171###Co-Author######H. Lee Moffitt Cancer Center and Research Institute###Co-Author: Mihaela Druta, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Ricardo Gonzalez, MD – Moffitt Cancer Center ### 2102172###Co-Author###Chair, Sarcoma Department###Moffitt Cancer Center###Co-Author: Ricardo Gonzalez, MD – Moffitt Cancer Center
### @@@ Eric Toloza, MD, PhD – Moffitt Cancer Center ### 2102173###Co-Author###Senior Member###Moffitt Cancer Center###Co-Author: Eric Toloza, MD, PhD – Moffitt Cancer Center
### @@@ Cheryl Cox, MS – Moffitt Cancer Center ### 2102174###Co-Author###Director of Operations, Cell Therapy Core Facility###Moffitt Cancer Center###Co-Author: Cheryl Cox, MS – Moffitt Cancer Center
### @@@ Amod Sarnaik, MD – Moffitt Cancer Center ### 2102175###Co-Author###Senior Member###Moffitt Cancer Center###Co-Author: Amod Sarnaik, MD – Moffitt Cancer Center
### @@@ Shari Pilon-Thomas, PhD – Moffitt Cancer Center ### 2102176###Co-Author###Senior Member###Moffitt Cancer Center###Co-Author: Shari Pilon-Thomas, PhD – Moffitt Cancer Center
### Paper 33Author: Patrick Schöffski, MD, MPH – Department of General Medical Oncology, University Hospitals Leuven, and Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium
### @@@ Patricia LoRusso, MD – Yale University School of Medicine, Yale Cancer Center ### 2102186###Co-Author######Yale University School of Medicine, Yale Cancer Center###Co-Author: Patricia LoRusso, MD – Yale University School of Medicine, Yale Cancer Center
### @@@ Noboru Yamamoto, MD – Department of Experimental Therapeutics, National Cancer Center Hospital ### 2102187###Co-Author######Department of Experimental Therapeutics, National Cancer Center Hospital###Co-Author: Noboru Yamamoto, MD – Department of Experimental Therapeutics, National Cancer Center Hospital
### @@@ Iwona Lugowska, MD – Early Phase Clinical Trials Unit, Maria Skłodowska Curie National Research Institute of Oncology ### 2102188###Co-Author######Early Phase Clinical Trials Unit, Maria Skłodowska Curie National Research Institute of Oncology###Co-Author: Iwona Lugowska, MD – Early Phase Clinical Trials Unit, Maria Skłodowska Curie National Research Institute of Oncology
### @@@ Victor Moreno, PhD – START Madrid-FJD, Fundación Jiménez Díaz ### 2102189###Co-Author###Director of START Madrid-FJD###START Madrid-FJD, Fundación Jiménez Díaz###Co-Author: Victor Moreno, PhD – START Madrid-FJD, Fundación Jiménez Díaz
### @@@ Ulrich M. Lauer, MD – Department of Medical Oncology & Pneumology and Tübingen Early Phase Clinical Trials Unit, University Hospital Tübingen ### 2102190###Co-Author######Department of Medical Oncology & Pneumology and Tübingen Early Phase Clinical Trials Unit, University Hospital Tübingen###Co-Author: Ulrich M. Lauer, MD – Department of Medical Oncology & Pneumology and Tübingen Early Phase Clinical Trials Unit, University Hospital Tübingen
### @@@ Chenxiao Hu, MD – Boehringer Ingelheim Pharmaceuticals Inc. ### 2102191###Co-Author######Boehringer Ingelheim Pharmaceuticals Inc.###Co-Author: Chenxiao Hu, MD – Boehringer Ingelheim Pharmaceuticals Inc.
### @@@ Sara Durland-Busbice, MD – Boehringer Ingelheim Pharmaceuticals Inc. ### 2102192###Co-Author######Boehringer Ingelheim Pharmaceuticals Inc.###Co-Author: Sara Durland-Busbice, MD – Boehringer Ingelheim Pharmaceuticals Inc.
### @@@ Girish Jayadeva, MD – Boehringer Ingelheim Pharmaceuticals Inc. ### 2102193###Co-Author######Boehringer Ingelheim Pharmaceuticals Inc.###Co-Author: Girish Jayadeva, MD – Boehringer Ingelheim Pharmaceuticals Inc.
### @@@ Mehdi Lahmar, MD (he/him/his) – Boehringer Ingelheim International GmbH ### 2102194###Co-Author###Clinical Program Leader###Boehringer Ingelheim International GmbH###Co-Author: Mehdi Lahmar, MD (he/him/his) – Boehringer Ingelheim International GmbH
### he/him/his @@@ Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center ### 2101875###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center
### Paper 23Author: Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research
### he/him/his @@@ Varun Monga, MBBS (he/him/his) – UCSF Helen Diller Family Comprehensive Cancer Center ### 2102060###Co-Author###Associate Clinical Professor###UCSF Helen Diller Family Comprehensive Cancer Center###Co-Author: Varun Monga, MBBS (he/him/his) – UCSF Helen Diller Family Comprehensive Cancer Center
### he/him/his @@@ John Charlson, MD (he/him/his) – Medical College of Wisconsin ### 2102061###Co-Author###Associate Professor###Medical College of Wisconsin###Co-Author: John Charlson, MD (he/him/his) – Medical College of Wisconsin
### he/him/his @@@ Brian Schulte, MD – UCSF Helen Diller Family Comprehensive Cancer Center ### 2102062###Co-Author###Assistant Professor###UCSF Helen Diller Family Comprehensive Cancer Center###Co-Author: Brian Schulte, MD – UCSF Helen Diller Family Comprehensive Cancer Center
### @@@ Mohammed Milhem, MBBS – University of Iowa, Holden Comprehensive Cancer Center ### 2102064###Co-Author###Division Director, Hematology/Oncology###University of Iowa, Holden Comprehensive Cancer Center###Co-Author: Mohammed Milhem, MBBS – University of Iowa, Holden Comprehensive Cancer Center
### @@@ Paul Frankel, MD – City of Hope Comprehensive Cancer Center ### 2102065###Co-Author######City of Hope Comprehensive Cancer Center###Co-Author: Paul Frankel, MD – City of Hope Comprehensive Cancer Center
### @@@ Brian Van Tine, MD – Washington University in St. Louis ### 2102066###Co-Author######Washington University in St. Louis###Co-Author: Brian Van Tine, MD – Washington University in St. Louis
### @@@ Mia C. Weiss, MD – Washington University School of Medicine ### 2102067###Co-Author###Assistant Professor of Medicine###Washington University School of Medicine###Co-Author: Mia C. Weiss, MD – Washington University School of Medicine
### @@@ Angela Hirbe, MD,PHD – Washington University in St. Louis ### 2102068###Co-Author###Assistant Professor of Medicine and Pediatrics###Washington University in St. Louis###Co-Author: Angela Hirbe, MD,PHD – Washington University in St. Louis
### @@@ Seth Pollack, MD – Robert H. Lurie Comprehensive Cancer Center of Northwestern University ### 2101861###Co-Author###Sarcoma Program Director###Robert H. Lurie Comprehensive Cancer Center of Northwestern University###Co-Author: Seth Pollack, MD – Robert H. Lurie Comprehensive Cancer Center of Northwestern University
### @@@ Pedro Viveiros, MD – Northwestern University ### 2102069###Co-Author###Assistant Professor###Northwestern University###Co-Author: Pedro Viveiros, MD – Northwestern University
### @@@ Scott Okuno, M.D. – Mayo Clinic ### 2102070###Co-Author######Mayo Clinic###Co-Author: Scott Okuno, M.D. – Mayo Clinic
### @@@ Steven Attia, D.O. – Mayo Clinic ### 2101930###Co-Author###Consultant###Mayo Clinic###Co-Author: Steven Attia, D.O. – Mayo Clinic
### @@@ Brittany Siontis, MD – Mayo Clinic ### 2102071###Co-Author###Assistant Professor of Oncology###Mayo Clinic###Co-Author: Brittany Siontis, MD – Mayo Clinic
### @@@ Steven Robinson, MBBS – Mayo Clinic ### 2102072###Co-Author###Associate Professor of Oncology###Mayo Clinic###Co-Author: Steven Robinson, MBBS – Mayo Clinic
### @@@ Janet Yoon, MD – City of Hope Comprehensive Cancer Center ### 2102073###Co-Author###Clinical professor of pediatrics###City of Hope Comprehensive Cancer Center###Co-Author: Janet Yoon, MD – City of Hope Comprehensive Cancer Center
### Paper 22Author: Shantanu Banerji, MD, FRCPC (he/him/his) – CancerCare Manitoba
### he/him/his @@@ Abha Gupta, MD MSc – Princess Margaret Cancer Center ### 2102463###Co-Author###Staff Oncologist###Princess Margaret Cancer Center###Co-Author: Abha Gupta, MD MSc – Princess Margaret Cancer Center
### @@@ Albiruni Ryan Abdul Razak, MB BCh, BM BCh – Princess Margaret Cancer Center ### 2101867###Co-Author######Princess Margaret Cancer Center###Co-Author: Albiruni Ryan Abdul Razak, MB BCh, BM BCh – Princess Margaret Cancer Center
### @@@ Thierry Alcindor, MD – Harvard University,, Dana-Farber Cancer Center ### 2102523###Co-Author######Harvard University,, Dana-Farber Cancer Center###Co-Author: Thierry Alcindor, MD – Harvard University,, Dana-Farber Cancer Center
### @@@ Quincy Chu, MD – Cross Cancer Institute ### 2102524###Co-Author######Cross Cancer Institute###Co-Author: Quincy Chu, MD – Cross Cancer Institute
### @@@ Karen A. Gelmon, MD (she/her/hers) – BC Cancer ### 2102525###Co-Author###Professor of Medicine, Medical Oncologist###BC Cancer###Co-Author: Karen A. Gelmon, MD (she/her/hers) – BC Cancer
### she/her/hers @@@ Garth Nicholas, MD – Ottawa Hospital Research Institute ### 2102526###Co-Author###Medical Oncologist###Ottawa Hospital Research Institute###Co-Author: Garth Nicholas, MD – Ottawa Hospital Research Institute
### @@@ Eric Winquist, MD (he/him/his) – Western University ### 2102527###Co-Author###Professor###Western University###Co-Author: Eric Winquist, MD (he/him/his) – Western University
### he/him/his @@@ Kamal Haider, MD – Saskatoon Cancer Centre ### 2102528###Co-Author######Saskatoon Cancer Centre###Co-Author: Kamal Haider, MD – Saskatoon Cancer Centre
### @@@ Torsten O. Nielsen, MD, PhD – Department of Pathology and Laboratory Medicine, University of British Columbia ### 2102529###Co-Author###Professor###Department of Pathology and Laboratory Medicine, University of British Columbia###Co-Author: Torsten O. Nielsen, MD, PhD – Department of Pathology and Laboratory Medicine, University of British Columbia
### @@@ Ming Tsao, MD, FRCPC – Princess Margaret Cancer Centre ### 2102530###Co-Author######Princess Margaret Cancer Centre###Co-Author: Ming Tsao, MD, FRCPC – Princess Margaret Cancer Centre
### @@@ Tricia Cottrell, MD – Canadian Cancer Trials Group ### 2102531###Co-Author######Canadian Cancer Trials Group###Co-Author: Tricia Cottrell, MD – Canadian Cancer Trials Group
### @@@ Joana Sederias, n/a – Canadian Cancer Trials Group ### 2102532###Co-Author######Canadian Cancer Trials Group###Co-Author: Joana Sederias, n/a – Canadian Cancer Trials Group
### @@@ Siwei Zhang, n/a – Canadian Cancer Trials Group ### 2102533###Co-Author######Canadian Cancer Trials Group###Co-Author: Siwei Zhang, n/a – Canadian Cancer Trials Group
### @@@ Wei Tu, n/a – Canadian Cancer Trials Group ### 2102534###Co-Author######Canadian Cancer Trials Group###Co-Author: Wei Tu, n/a – Canadian Cancer Trials Group
### @@@ Janet Dancey, MD – Canadian Cancer Trials Group ### 2102535###Co-Author######Canadian Cancer Trials Group###Co-Author: Janet Dancey, MD – Canadian Cancer Trials Group
### Paper 34Author: Jyoti Bajpai, MD, DM (she/her/hers) – Tata Memorial Centre,Homibhabha National University,Mumbai,India
### she/her/hers @@@ Laboni Sarkar, MD – Tata Memorial Hospital Mumbai ### 2102218###Co-Author###Senior Resident###Tata Memorial Hospital Mumbai###Co-Author: Laboni Sarkar, MD – Tata Memorial Hospital Mumbai
### @@@ Sushmita Rath, D.M. – Tata Memorial Hospital Mumbai ### 2102219###Co-Author###Associate Professor Medical Oncology ###Tata Memorial Hospital Mumbai###Co-Author: Sushmita Rath, D.M. – Tata Memorial Hospital Mumbai
### @@@ Prabhat Bhargava, D.M. (he/him/his) – Tata Memorial Hospital Mumbai ### 2102220###Co-Author###Associate Professor###Tata Memorial Hospital Mumbai###Co-Author: Prabhat Bhargava, D.M. (he/him/his) – Tata Memorial Hospital Mumbai
### he/him/his @@@ Bharat Rekhi, MD DNB FRCPATH (he/him/his) – Tata Memorial Hospital Mumbai ### 2102221###Co-Author###PROFESSOR, PATHOLOGIST###Tata Memorial Hospital Mumbai###Co-Author: Bharat Rekhi, MD DNB FRCPATH (he/him/his) – Tata Memorial Hospital Mumbai
### he/him/his @@@ Shripad D Banavali, MD – Tata memorial Centre, Mumbai ### 2102222###Co-Author######Tata memorial Centre, Mumbai###Co-Author: Shripad D Banavali, MD – Tata memorial Centre, Mumbai
### Paper 50Author: Stefano Testa, MD (he/him/his) – Beth Israel Deaconess Medical Center
### he/him/his @@@ Minggui Pan, MD (he/him/his) – Stanford University ### 2102921###Co-Author###Clinical Professor###Stanford University###Co-Author: Minggui Pan, MD (he/him/his) – Stanford University
### he/him/his @@@ Nam Bui, MD – Stanford University ### 2101851###Co-Author######Stanford University###Co-Author: Nam Bui, MD – Stanford University
### @@@ Kristen N. Ganjoo, MD – Stanford Cancer Center ### 2102407###Co-Author###Professor of Medicine (Oncology)###Stanford Cancer Center###Co-Author: Kristen N. Ganjoo, MD – Stanford Cancer Center
### @@@ Matt van de Rijn, M.D. (he/him/his) – Stanford University ### 1136416###Co-Author###Professor of Pathology###Stanford University###Co-Author: Matt van de Rijn, M.D. (he/him/his) – Stanford University
### he/him/his @@@ Anusha Kalbasi, M.D. – Stanford University ### 2102922###Co-Author###Associate Professor###Stanford University###Co-Author: Anusha Kalbasi, M.D. – Stanford University
### @@@ Everett J. Moding, MD, PhD (he/him/his) – Stanford University ### 2102687###Co-Author###Assistant Professor###Stanford University###Co-Author: Everett J. Moding, MD, PhD (he/him/his) – Stanford University
### he/him/his Paper 13Presenter: Una Hayden, RN HDip MSc – Tallaght University Hospital
### @@@ Hazel Murray, n/a – SVUH ### 2104954###Presenter######SVUH###Presenter: Hazel Murray, n/a – SVUH
###Author: Adam M. Burgoyne, MD, PhD – UC San Diego Moores Cancer Center
### @@@ Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute ### 2101916###Co-Author###Professor of Medicine###Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute###Co-Author: Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute
### @@@ Margaret von Mehren, MD (she/her/hers) – Fox Chase Cancer Center ### 2102009###Co-Author###Director of Sarcoma Oncology###Fox Chase Cancer Center###Co-Author: Margaret von Mehren, MD (she/her/hers) – Fox Chase Cancer Center
### she/her/hers @@@ Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 2101926###Co-Author###Professor of Medicine###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Paul T. Fanta, MD – Department of Medicine, Division of Medical Oncology, University of California San Diego ### 2102010###Co-Author###Professor###Department of Medicine, Division of Medical Oncology, University of California San Diego###Co-Author: Paul T. Fanta, MD – Department of Medicine, Division of Medical Oncology, University of California San Diego
### @@@ Michael Hahn, MD, PhD – UC San Diego Moores Cancer Center ### 2102011###Co-Author######UC San Diego Moores Cancer Center###Co-Author: Michael Hahn, MD, PhD – UC San Diego Moores Cancer Center
### @@@ Christian Metallo, PhD – Salk Institute for Biological Studies ### 2102012###Co-Author######Salk Institute for Biological Studies###Co-Author: Christian Metallo, PhD – Salk Institute for Biological Studies
### @@@ Elaine Eng, FNP-BC, MSN – UC San Diego Moores Cancer Center ### 2102013###Co-Author###Consultant###UC San Diego Moores Cancer Center###Co-Author: Elaine Eng, FNP-BC, MSN – UC San Diego Moores Cancer Center
### @@@ Minya Pu, PhD – UC San Diego Moores Cancer Center ### 2102014###Co-Author######UC San Diego Moores Cancer Center###Co-Author: Minya Pu, PhD – UC San Diego Moores Cancer Center
### @@@ Emily Pittman, PhD – UC San Diego Moores Cancer Center ### 2102015###Co-Author###Program Manager###UC San Diego Moores Cancer Center###Co-Author: Emily Pittman, PhD – UC San Diego Moores Cancer Center
### @@@ Karen Messer, PhD – UC San Diego Moores Cancer Center ### 2102016###Co-Author######UC San Diego Moores Cancer Center###Co-Author: Karen Messer, PhD – UC San Diego Moores Cancer Center
### @@@ Jason K. Sicklick, M.D., FACS – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102017###Co-Author###Professor###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Jason K. Sicklick, M.D., FACS – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### Paper 83Video Presenter: Andrew J. Hayes, MBBS FRCS, PhD – Royal Marsden Hospital
### @@@ Michelle Wilkinson, MD PhD – Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust ### 2102434###Co-Author######Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust###Co-Author: Michelle Wilkinson, MD PhD – Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust
### Video 03Co-Author: James B. Reinecke, MD, PhD – Nationwide Children's Hospital
### @@@ Leyre Jimenez Garcia, BS (she/her/hers) – Nationwide Children's Hospital ### 2102442###Co-Author###Graduate Research Associate###Nationwide Children's Hospital###Co-Author: Leyre Jimenez Garcia, BS (she/her/hers) – Nationwide Children's Hospital
### she/her/hers @@@ Amy C. Gross, MS (she/her/hers) – Nationwide Children's Hospital ### 2102443###Co-Author###Research Project Manager###Nationwide Children's Hospital###Co-Author: Amy C. Gross, MS (she/her/hers) – Nationwide Children's Hospital
### she/her/hers @@@ Maren Cam, PhD (she/her/hers) – Nationwide Children's Hospital ### 2102444###Co-Author###Research Scientist###Nationwide Children's Hospital###Co-Author: Maren Cam, PhD (she/her/hers) – Nationwide Children's Hospital
### she/her/hers @@@ Ryan D. Roberts, MD, PhD – Nationwide Children's Hospital ### 2102445###Author###Associate Professor###Nationwide Children's Hospital###Author: Ryan D. Roberts, MD, PhD – Nationwide Children's Hospital
### Paper 06Co-Author: Hannah Bender, MD (she/her/hers) – Boston Combined Residency Program
### she/her/hers @@@ Zheng Kuang, MS (he/him/his) – Foundation Medicine Inc. ### 2102156###Co-Author###Scientist I###Foundation Medicine Inc.###Co-Author: Zheng Kuang, MS (he/him/his) – Foundation Medicine Inc.
### he/him/his @@@ Lorena Lazo de la Vega, PhD (she/her/hers) – Dana-Farber Cancer Institute ### 2102157###Co-Author###Senior Clinical Genomics Scientist###Dana-Farber Cancer Institute###Co-Author: Lorena Lazo de la Vega, PhD (she/her/hers) – Dana-Farber Cancer Institute
### she/her/hers @@@ Evelina Ceca, MBA – Dana-Farber Cancer Institute ### 2102158###Co-Author######Dana-Farber Cancer Institute###Co-Author: Evelina Ceca, MBA – Dana-Farber Cancer Institute
### @@@ Julia Schiantarelli, MD – Boston Children's Hospital ### 2102159###Co-Author######Boston Children's Hospital###Co-Author: Julia Schiantarelli, MD – Boston Children's Hospital
### @@@ Julius Honecker, PhD – Foundation Medicine ### 2102160###Co-Author######Foundation Medicine###Co-Author: Julius Honecker, PhD – Foundation Medicine
### @@@ Matthew Hiemenz, MD (he/him/his) – Foundation Medicine ### 2102162###Co-Author###Senior Pathologist###Foundation Medicine###Co-Author: Matthew Hiemenz, MD (he/him/his) – Foundation Medicine
### he/him/his @@@ Suzanne J. Forrest, MD (she/her/hers) – Dana-Farber Cancer Institute ### 2102164###Author###Attending Physician###Dana-Farber Cancer Institute###Author: Suzanne J. Forrest, MD (she/her/hers) – Dana-Farber Cancer Institute
### she/her/hers @@@ Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2101994###Presenter######Dana-Farber/Boston Children's Cancer and Blood Disorders Center###Presenter: Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### Paper 45Author: Ashwyn K. Sharma, M.D. – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### @@@ Alexander T. Wenzel, B.S. – Department of Medicine, University of California San Diego ### 2102242###Co-Author###PhD Student###Department of Medicine, University of California San Diego###Co-Author: Alexander T. Wenzel, B.S. – Department of Medicine, University of California San Diego
### @@@ John Jun, B.S. – Department of Medicine, University of California San Diego ### 2102243###Co-Author###Bioinformatics Scientist###Department of Medicine, University of California San Diego###Co-Author: John Jun, B.S. – Department of Medicine, University of California San Diego
### @@@ Diwakar Guragain, PhD (he/him/his) – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102244###Co-Author###Postdoctoral Employee###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Diwakar Guragain, PhD (he/him/his) – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### he/him/his @@@ Chih-Min Tang, Ph.D. – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102245###Co-Author###Staff Research Associate-3###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Chih-Min Tang, Ph.D. – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### @@@ Shruti Bhargava, Ph.D. – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102246###Co-Author###Postdoctoral Employee###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Shruti Bhargava, Ph.D. – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### @@@ Adam M. Burgoyne, MD, PhD (he/him/his) – Department of Medicine, Division of Hematology-Oncology, UC San Diego Health ### 2102247###Co-Author###Associate Clinical Professor###Department of Medicine, Division of Hematology-Oncology, UC San Diego Health###Co-Author: Adam M. Burgoyne, MD, PhD (he/him/his) – Department of Medicine, Division of Hematology-Oncology, UC San Diego Health
### he/him/his @@@ Paul T. Fanta, MD – Department of Medicine, Division of Medical Oncology, University of California San Diego ### 2102010###Co-Author###Professor###Department of Medicine, Division of Medical Oncology, University of California San Diego###Co-Author: Paul T. Fanta, MD – Department of Medicine, Division of Medical Oncology, University of California San Diego
### @@@ Sadie E. Munter, B.A. – Department of Surgery, University of California San Diego ### 2102248###Co-Author###Medical Student###Department of Surgery, University of California San Diego###Co-Author: Sadie E. Munter, B.A. – Department of Surgery, University of California San Diego
### @@@ Katherine Y. Chen, B.S. – Department of Surgery, University of California San Diego ### 2102249###Co-Author###Medical Student###Department of Surgery, University of California San Diego###Co-Author: Katherine Y. Chen, B.S. – Department of Surgery, University of California San Diego
### @@@ Terrence M. Doherty, B.A. – Moores Cancer Center, University of California San Diego ### 2102250###Co-Author###Senior Science Writer###Moores Cancer Center, University of California San Diego###Co-Author: Terrence M. Doherty, B.A. – Moores Cancer Center, University of California San Diego
### @@@ Manikandan Murugesan, PhD (he/him/his) – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102251###Co-Author###Postdoctoral Employee###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Manikandan Murugesan, PhD (he/him/his) – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### he/him/his @@@ Adrian Sanchez-Fdez, PhD – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102252###Co-Author###Postdoctoral Employee###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Adrian Sanchez-Fdez, PhD – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### @@@ Shashwath Kalladi Malli, PhD – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102253###Co-Author###Postdoctoral Employee###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Shashwath Kalladi Malli, PhD – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### @@@ Prabhjot S. Mundi, M.D. – Department of Medicine, Columbia University ### 2102254###Co-Author###Assistant Professor###Department of Medicine, Columbia University###Co-Author: Prabhjot S. Mundi, M.D. – Department of Medicine, Columbia University
### @@@ Sara Rothschild, M.P.H. – The Life Raft Group ### 2102255###Co-Author###Executive Director###The Life Raft Group###Co-Author: Sara Rothschild, M.P.H. – The Life Raft Group
### @@@ Denisse Evans, M.S. – The Life Raft Group ### 2102256###Co-Author###Senior Director, Data Mgmt. & Research###The Life Raft Group###Co-Author: Denisse Evans, M.S. – The Life Raft Group
### @@@ William Kim, Ph.D. – Department of Medicine, University of California San Diego ### 2102257###Co-Author###Assistant Professor###Department of Medicine, University of California San Diego###Co-Author: William Kim, Ph.D. – Department of Medicine, University of California San Diego
### @@@ Gary K. Schwartz, MD – Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine ### 2101874###Co-Author###Professor###Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine###Co-Author: Gary K. Schwartz, MD – Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine
### @@@ Andrea Califano, PhD – Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University ### 2102258###Co-Author###Professor###Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University###Co-Author: Andrea Califano, PhD – Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University
### @@@ Pablo Tamayo, Ph.D. – Department of Medicine, University of California San Diego ### 2102259###Co-Author###Professor###Department of Medicine, University of California San Diego###Co-Author: Pablo Tamayo, Ph.D. – Department of Medicine, University of California San Diego
### @@@ Jill P. Mesirov, PhD – Department of Medicine, Division of Genomics and Precision Medicine, University of California San Diego ### 2102260###Co-Author###Professor###Department of Medicine, Division of Genomics and Precision Medicine, University of California San Diego###Co-Author: Jill P. Mesirov, PhD – Department of Medicine, Division of Genomics and Precision Medicine, University of California San Diego
### @@@ Jason K. Sicklick, M.D., FACS – Department of Surgery, Division of Surgical Oncology, University of California San Diego ### 2102017###Co-Author###Professor###Department of Surgery, Division of Surgical Oncology, University of California San Diego###Co-Author: Jason K. Sicklick, M.D., FACS – Department of Surgery, Division of Surgical Oncology, University of California San Diego
### Paper 86Author: Dimosthenis Andreou, MD – Medical University of Graz
### @@@ Stefanie Hecker-Nolting, MD (she/her/hers) – Olgahospital Stuttgart ### 2102475###Co-Author###Senior physician###Olgahospital Stuttgart###Co-Author: Stefanie Hecker-Nolting, MD (she/her/hers) – Olgahospital Stuttgart
### she/her/hers @@@ Matthew R. Sydes, CStat (he/him/his) – University College London ### 2102476###Co-Author###Professor of Clinical Trials and Methodology###University College London###Co-Author: Matthew R. Sydes, CStat (he/him/his) – University College London
### he/him/his @@@ Daniel Baumhoer, MD (he/him/his) – University Hospital Basel ### 2102477###Co-Author###Consultant Pathologist###University Hospital Basel###Co-Author: Daniel Baumhoer, MD (he/him/his) – University Hospital Basel
### he/him/his @@@ Odion Binitie, MD – H. Lee Moffitt Cancer Center ### 2101986###Co-Author###Associate Professor###H. Lee Moffitt Cancer Center###Co-Author: Odion Binitie, MD – H. Lee Moffitt Cancer Center
### @@@ Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2101994###Co-Author######Dana-Farber/Boston Children's Cancer and Blood Disorders Center###Co-Author: Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Leo Kager, MD – St. Anna Children's Hospital and Children's Cancer Research Institute ### 2102478###Co-Author######St. Anna Children's Hospital and Children's Cancer Research Institute###Co-Author: Leo Kager, MD – St. Anna Children's Hospital and Children's Cancer Research Institute
### @@@ Matthias Kevric, n/a – Olgahospital Stuttgart ### 2102479###Co-Author######Olgahospital Stuttgart###Co-Author: Matthias Kevric, n/a – Olgahospital Stuttgart
### @@@ Thomas Kühne, MD – University Children's Hospital Basel ### 2102480###Co-Author###Acting Head###University Children's Hospital Basel###Co-Author: Thomas Kühne, MD – University Children's Hospital Basel
### @@@ Andreas Leithner, Prof. MD (he/him/his) – Medical University of Graz ### 2102481###Co-Author###Head of Department###Medical University of Graz###Co-Author: Andreas Leithner, Prof. MD (he/him/his) – Medical University of Graz
### he/him/his @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Co-Author######Moffitt Cancer Center###Co-Author: Damon Reed, MD – Moffitt Cancer Center
### @@@ Elyssa Rubin, MD – Children's Hospital of Orange County ### 2102056###Co-Author###PSF Director of Bone and Soft Tissue Tumor Program###Children's Hospital of Orange County###Co-Author: Elyssa Rubin, MD – Children's Hospital of Orange County
### @@@ Sigbjørn Smeland, MD – Oslo University Hospital ### 2102482###Co-Author######Oslo University Hospital###Co-Author: Sigbjørn Smeland, MD – Oslo University Hospital
### @@@ Benjamin Sorg, n/a – Olgahospital Stuttgart ### 2102483###Co-Author######Olgahospital Stuttgart###Co-Author: Benjamin Sorg, n/a – Olgahospital Stuttgart
### @@@ Sandra Strauss, MD, PhD – University Collegue of London (UCL) ### 2102402###Co-Author######University Collegue of London (UCL)###Co-Author: Sandra Strauss, MD, PhD – University Collegue of London (UCL)
### @@@ Per-Ulf Tunn, MD – Helios Hospital Berlin-Buch ### 2102484###Co-Author######Helios Hospital Berlin-Buch###Co-Author: Per-Ulf Tunn, MD – Helios Hospital Berlin-Buch
### @@@ Reinhard Windhager, MD – Medical University of Vienna ### 2102485###Co-Author######Medical University of Vienna###Co-Author: Reinhard Windhager, MD – Medical University of Vienna
### @@@ Stefan S. Bielack, MD, PhD (he/him/his) – Olgahospital Stuttgart ### 2102486###Co-Author###Arzt ###Olgahospital Stuttgart###Co-Author: Stefan S. Bielack, MD, PhD (he/him/his) – Olgahospital Stuttgart
### he/him/his Paper 66